Free Trial
NASDAQ:QNTM

Quantum Biopharma (QNTM) Stock Price, News & Analysis

Quantum Biopharma logo
$29.14 +3.13 (+12.03%)
Closing price 04:00 PM Eastern
Extended Trading
$29.02 -0.12 (-0.39%)
As of 05:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Quantum Biopharma Stock (NASDAQ:QNTM)

Key Stats

Today's Range
$26.94
$29.25
50-Day Range
$13.45
$35.00
52-Week Range
$2.70
$38.25
Volume
214,152 shs
Average Volume
1.28 million shs
Market Capitalization
$84.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive QNTM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quantum Biopharma and its competitors with MarketBeat's FREE daily newsletter.

QNTM Stock News Headlines

Critical AI announcement set to ignite AI 2.0
A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbling. But for smart traders, this isn’t chaos. It’s opportunity. One veteran trader is revealing how his simple system spots fast setups in moments like this—no guesswork, no complicated strategies, and no big account required.
Quantum BioPharma Makes Strategic Investment in GameStop
See More Headlines

QNTM Stock Analysis - Frequently Asked Questions

Quantum Biopharma's stock was trading at $3.68 at the beginning of the year. Since then, QNTM stock has increased by 651.1% and is now trading at $27.64.

Quantum Biopharma Ltd. (NASDAQ:QNTM) posted its earnings results on Wednesday, August, 6th. The company reported ($3.23) earnings per share for the quarter, missing analysts' consensus estimates of ($0.17) by $3.06.

Quantum Biopharma's top institutional investors include AdvisorShares Investments LLC (1.27%).

Shares of QNTM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Quantum Biopharma investors own include Jiuzi (JZXN), Aethlon Medical (AEMD), Aditxt (ADTX), Adial Pharmaceuticals (ADIL), Avalon GloboCare (ALBT), Ainos (AIMD) and AMC Entertainment (AMC).

Company Calendar

Last Earnings
8/06/2025
Today
8/08/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:QNTM
Previous Symbol
NASDAQ:QNTM
CIK
1771885
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($14.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.20 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-216.35%
Return on Assets
-128.55%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.96
Quick Ratio
0.95

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.54 per share
Price / Book
6.42

Miscellaneous

Outstanding Shares
2,908,000
Free Float
2,660,000
Market Cap
$84.74 million
Optionable
N/A
Beta
0.71
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:QNTM) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners